Variants of SARS Coronavirus-2 and Their Potential Impact on the Future of the COVID-19 Pandemic

The emergence of SARS-CoV-2 variants of concern (VOCs), especially the sweeping spread of the delta variant, and differing public health management strategies, have rendered global eradication of SARS-CoV-2 unlikely. The currently available COVID-19 vaccines, including the inactivated whole virus vaccines, mRNA vaccines, and adenovirus-vectored vaccines, are effective in protecting people from severe disease and death from COVID-19, but they may not confer good mucosal immunity to prevent the establishment of infection and subsequent viral shedding and transmission. Mucosal vaccines delivered via intranasal route may provide a promising direction, which, if given as a third dose after a two-dose series of intramuscular vaccination, likely promotes mucosal immunity in addition to boosting the systemic cell-mediated immunity and antibody response. However, immunity induced by vaccination, and natural infection as well, is likely to wane followed by re-infection as in the case of human coronaviruses OC43, 229E, NL63, and HKU1. It is a challenge to prevent and control COVID-19 worldwide with the increasing number of VOCs associated with increased transmissibility and changing antigenicity. Nevertheless, we may seek to end the current pandemic situation through mass vaccination and gradual relaxation of non-pharmaceutical measures, which would limit the incidence of severe COVID-19. Repeated doses of booster vaccine will likely be required, similar to influenza virus, especially for the elderly and the immunocompromised patients who are most vulnerable to infection

Cardiac Involvement related to COVID-19 Infection and Vaccination in Children and Adolescents – Hong Kong's Perspective

Myocarditis and Pericarditis have many virological and immunological causes. This article described the SARS-CoV involvement to the heart in children and adolescents, also the entity Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but severe consequence of SARS-CoV2 infection. Hong Kong case definition of MIS-C was listed. The consensus from overseas experts was that MIS-C should be managed by multidisciplinary team with a structured long-term follow-up to monitor the functioning of various organs and ascertain the prognosis. The side effect mRNA vaccination causing myocarditis and pericarditis is also concern of paediatricians worldwide. Hong Kong published local epidemiology of acute myocarditis and pericarditis among adolescents following Comirnaty vaccination, the local and overseas data were used in fine-tuning the COVID vaccination program in children and adolescents. To prevent severe and fatal outcome of COVID-19 diseases, it is important to educate the public and to promote COVID-19 vaccination in the community, also to continue monitoring the safety of the available vaccines

Temporal trends and patterns of infective endocarditis in a Chinese population:A territory-wide study in Hong Kong (2002-2019)

BACKGROUND: The characteristics of infective endocarditis (IE) in Asians are poorly understood. Therefore, we aim to describe the epidemiological trends and clinical features of IE in Hong Kong. METHODS: All patients with incident IE from 2002–2019 in a territory-wide clinical database in Hong Kong were identified. We studied the age- and sex-adjusted and one-year mortality of IE between 2002 and 2019 and identified significant contributors to 1-year all-cause death using the attributable fraction. We used propensity score and inverse propensity of treatment weighting to study the association of surgery with mortality. FINDINGS: A total of 5139 patients (60.4 ± 18.2years, 37% women) were included. The overall incidence of IE was 4.9 per 100,000 person-year, which did not change over time (P = 0.17). Patients in 2019 were older and more comorbid than those in 2002. The one-year crude mortality rate was 30% in 2002, which did not change significantly over time (P = 0.10). Between 2002 and 2019, the rate of surgery increased and was associated with a 51% risk reduction in 1-year all-cause mortality (Hazard Ratio 0.49 [0.28–0.87], P = 0.015). Advanced age (attributable fraction 19%) and comorbidities (attributable fraction 15%) were significant contributors to death. INTERPRETATION: The incidence of IE in Hong Kong did not change between 2002 and 2019. Patients with IE in 2019 were older and had more comorbidities than those in 2002. Mortality of IE remains persistently high in Hong Kong. Together, these data can guide public health strategies to improve the outcomes of patients with IE. FUNDING: This work was supported by Sanming Project of Medicine in Shenzhen, China [No. SZSM201911020] and HKU-SZH Fund for Shenzhen Key Medical Discipline [No. SZXK2020081]

The central role of natural killer cells in mediating acute myocarditis after mRNA COVID-19 vaccination

BACKGROUND: Vaccine-related acute myocarditis is recognized as a rare and specific vaccine complication following mRNA-based COVID-19 vaccinations. The precise mechanisms remain unclear. We hypothesized that natural killer (NK) cells play a central role in its pathogenesis. METHODS: Samples from 60 adolescents with vaccine-related myocarditis were analyzed, including pro-inflammatory cytokines, cardiac troponin T, genotyping, and immunophenotyping of the corresponding activation subsets of NK cells, monocytes, and T cells. Results were compared with samples from 10 vaccinated individuals without myocarditis and 10 healthy controls. FINDINGS: Phenotypically, high levels of serum cytokines pivotal for NK cells, including interleukin-1β (IL-1β), interferon α2 (IFN-α2), IL-12, and IFN-γ, were observed in post-vaccination patients with myocarditis, who also had high percentage of CD57 NK cells in blood, which in turn correlated positively with elevated levels of cardiac troponin T. Abundance of the CD57 NK subset was particularly prominent in males and in those after the second dose of vaccination. Genotypically, killer cell immunoglobulin-like receptor (KIR) KIR2DL5B(-)/KIR2DS3(+)/KIR2DS5(-)/KIR2DS4del(+) was a risk haplotype, in addition to single-nucleotide polymorphisms related to the NK cell-specific expression quantitative trait loci DNAM-1 and FuT11, which also correlated with cardiac troponin T levels in post-vaccination patients with myocarditis. CONCLUSION: Collectively, these data suggest that NK cell activation by mRNA COVID-19 vaccine contributed to the pathogenesis of acute myocarditis in genetically and epidemiologically vulnerable subjects

Towards a global partnership model in interprofessional education for cross-sector problem-solving

Objectives A partnership model in interprofessional education (IPE) is important in promoting a sense of global citizenship while preparing students for cross-sector problem-solving. However, the literature remains scant in providing useful guidance for the development of an IPE programme co-implemented by external partners. In this pioneering study, we describe the processes of forging global partnerships in co-implementing IPE and evaluate the programme in light of the preliminary data available. Methods This study is generally quantitative. We collected data from a total of 747 health and social care students from four higher education institutions. We utilized a descriptive narrative format and a quantitative design to present our experiences of running IPE with external partners and performed independent t-tests and analysis of variance to examine pretest and posttest mean differences in students’ data. Results We identified factors in establishing a cross-institutional IPE programme. These factors include complementarity of expertise, mutual benefits, internet connectivity, interactivity of design, and time difference. We found significant pretest–posttest differences in students’ readiness for interprofessional learning (teamwork and collaboration, positive professional identity, roles, and responsibilities). We also found a significant decrease in students’ social interaction anxiety after the IPE simulation. Conclusions The narrative of our experiences described in this manuscript could be considered by higher education institutions seeking to forge meaningful external partnerships in their effort to establish interprofessional global health education

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Virological and host factors contributing to severe influenza

The pandemic influenza virus A(H1N1) of 2009 (A[H1N1]pdm09) and the avian influenza virus A(H7N9) of 2013 provided unique opportunities for studying severe influenza. This thesis investigated the pathogenesis of severe influenza and the virological or host factors contributing to disease severity in the hope of finding more effective treatment and prevention options. During the 2009 pandemic, both A(H1N1)pdm09 and pre-existing seasonal influenza viruses co-circulated and were associated with similar morbidity and mortality. When compared with seasonal influenza patients, A(H1N1)pdm09 patients were younger, more likely to be obese or pregnant, but less likely to have chronic illness. By assessing the change in type-specific and age-specific hemagglutinating antibody titers between the pre-pandemic and post-pandemic period, and combining data from laboratory-confirmed cases, patients aged ≥51 years were shown to be at a higher risk of severe A(H1N1)pdm09 infection when compared to younger patients. Patients with severe A(H1N1)pdm09 infection had rapidly progressive pneumonia. Postmortem histopathological studies showed diffuse alveolar damage in patients who died early and fibroproliferation in those who died late. Extrapulmonary complications were commonly observed. The clinical and histopathological features of A(H7N9) infection are similar to those of severe A(H1N1)pdm09 infections. Severe A(H1N1)pdm09 cases had a slower decline of viral load but persistently higher levels of IL-6, IL-10 and IL-15 than those of mild cases. There was no significant difference in the nasopharyngeal viral load between pandemic and seasonal A(H1N1)pdm09 patients. However, viremia was detected more frequently in patients with severe A(H1N1)pdm09 infection than those with mild infection. Viral polymorphisms which contribute to disease severity of A(H1N1)pdm09 or human adaptation of A(H5N1) and A(H7N9) were assessed. Hemagglutinin D225G substitution was found to be associated with severe A(H1N1)pdm09 infection, which were enriched in the lower respiratory tract and blood. A systematic bioinformatic analysis showed that hemagglutinin substitutions which enhance binding to human-type sialic acid receptors were more prevalent among A(H5N1) strains isolated from Egypt, where the prevalence of A(H5N1) human infection is highest in the world. L336M substitution of the PA protein, which is associated with enhanced viral replication, emerged as a novel A(H7N9) variant in Hong Kong. Humoral immunity is associated with antiviral effect and host inflammatory response. High titers of high avidity non-neutralizing antibodies that appeared within 2-4 days of symptom onset were associated with severe A(H1N1)pdm09 infection. Furthermore, a low plasma IgG2 titer was associated with dysregulated cytokine/chemokine response in severe cases. Genetic susceptibility study showed that variations in the CD55 and surfactant protein B gene were associated with severe A(H1N1)pdm09 infection. Obesity is a risk factor for severe A(H1N1)pdm09 infection. A high level of leptin was associated with mortality in obese mice with influenza virus infection, and anti-leptin antibody could protect obese mice from lethal challenge by A(H1N1)pdm09. Novel treatment and vaccination strategies were explored. Hyperimmune intravenous immunoglobulin treatment improved survival of severe A(H1N1)pdm09 infection, which demonstrated the importance of antibodies in treating influenza. A cell-culture based recombinant HA2 vaccine, which elicited anti-fusion antibodies, could protect mice from lethal challenge by A(H7N9), and the efficacy was improved with imiquimod.published_or_final_versionMicrobiologyMasterDoctor of Medicin

LA CARGA VIRAL SE DISPARA CUANDO LAS PERSONAS INFECTADAS COMIENZAN A SENTIRSE ENFERMAS

Analizaron muestras de saliva tosidas por 23 personas infectadas con SARS-CoV-2. El equipo descubri&oacute; que las concentraciones virales de los participantes del estudio alcanzaron su punto m&aacute;ximo poco despu&eacute;s de que comenzaron a sentirse enfermos, y comenzaron a disminuir aproximadamente una semana despu&eacute;s del pico